^
    Apply
    A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors (NCT06171282)
    Phase 1
    Shanghai Yunying Medical Technology
    Recruiting
    Last update posted :
    12/14/2023
    Initiation :
    07/12/2023
    Primary completion :
    07/12/2025
    Completion :
    07/12/2026
    IFNG • IL6 • TNFA • IL2 • IL10
    |
    R130
    A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors (NCT05961111)
    Phase 1
    Shanghai Yunying Medical Technology
    Recruiting
    Last update posted :
    07/27/2023
    Initiation :
    06/24/2023
    Primary completion :
    06/01/2025
    Completion :
    06/01/2026
    IL6 • CXCL8 • IL2 • IL10 • IL4
    |
    R130
    A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors (NCT05886075)
    Phase 1
    Shanghai Yunying Medical Technology
    Recruiting
    Last update posted :
    06/02/2023
    Initiation :
    03/30/2023
    Primary completion :
    03/01/2025
    Completion :
    03/01/2025
    IL6 • CXCL8 • IL2 • IL10 • IL4
    |
    R130
    A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors (NCT05860374)
    Phase 1
    Shanghai Yunying Medical Technology
    Recruiting
    Last update posted :
    05/16/2023
    Initiation :
    03/02/2023
    Primary completion :
    03/02/2025
    Completion :
    03/02/2026
    IL6 • CXCL8 • IL2 • IL10 • IL4
    |
    R130
    A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors (NCT05851456)
    Phase 1
    Shanghai Yunying Medical Technology
    Recruiting
    Last update posted :
    05/09/2023
    Initiation :
    04/10/2023
    Primary completion :
    04/01/2025
    Completion :
    04/01/2026
    IL6 • CXCL8 • IL2 • IL10 • IL4
    |
    R130
    A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer (NCT05830240)
    Phase 1
    Shanghai Yunying Medical Technology
    Recruiting
    Last update posted :
    04/26/2023
    Initiation :
    03/27/2023
    Primary completion :
    03/27/2025
    Completion :
    03/27/2026
    IL6 • CXCL8 • IL2 • IL10 • IL4
    |
    R130